EA202092273A1 - BICYCLIC CARBOXAMIDES AND METHODS OF THEIR APPLICATION - Google Patents

BICYCLIC CARBOXAMIDES AND METHODS OF THEIR APPLICATION

Info

Publication number
EA202092273A1
EA202092273A1 EA202092273A EA202092273A EA202092273A1 EA 202092273 A1 EA202092273 A1 EA 202092273A1 EA 202092273 A EA202092273 A EA 202092273A EA 202092273 A EA202092273 A EA 202092273A EA 202092273 A1 EA202092273 A1 EA 202092273A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
application
receptors
carboxamides
bicyclic
Prior art date
Application number
EA202092273A
Other languages
Russian (ru)
Inventor
Ялда Браво
Остин Чих-Ю Чэнь
Цзиньюэ Дин
Роберт Гомез
Хизер Лэм
Джо Фред Нагамизо
Рената Марселла Обалла
Дэвид Эндрю Пауэлл
Тао Шэн
Original Assignee
Темпест Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Темпест Терапьютикс, Инк. filed Critical Темпест Терапьютикс, Инк.
Priority claimed from PCT/US2019/027992 external-priority patent/WO2019204523A1/en
Publication of EA202092273A1 publication Critical patent/EA202092273A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединения, композиции и способы представлены для модуляции активности рецепторов EP2 и EP4 и для лечения, предупреждения и облегчения одного или более симптомов заболеваний или нарушений, связанных с активностью рецепторов EP2 и EP4. Согласно некоторым вариантам осуществления соединения представляют собой антагонисты обоих рецепторов EP2 и EP4.Compounds, compositions and methods are provided for modulating the activity of EP2 and EP4 receptors and for treating, preventing and ameliorating one or more symptoms of diseases or disorders associated with the activity of EP2 and EP4 receptors. In some embodiments, the compounds are antagonists of both EP2 and EP4 receptors.

EA202092273A 2018-10-17 2019-04-17 BICYCLIC CARBOXAMIDES AND METHODS OF THEIR APPLICATION EA202092273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862746843P 2018-10-17 2018-10-17
PCT/US2019/027992 WO2019204523A1 (en) 2018-04-17 2019-04-17 Bicyclic carboxamides and methods of use thereof

Publications (1)

Publication Number Publication Date
EA202092273A1 true EA202092273A1 (en) 2021-03-19

Family

ID=75262251

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092273A EA202092273A1 (en) 2018-10-17 2019-04-17 BICYCLIC CARBOXAMIDES AND METHODS OF THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202092273A1 (en)

Similar Documents

Publication Publication Date Title
EA201591403A1 (en) SPIROLACTAM NMDA RECEPTOR MODULATORS AND THEIR APPLICATION
EA201691872A1 (en) HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS
MX2020010879A (en) Bicyclic carboxamides and methods of use thereof.
EA201890453A1 (en) ANTI-ANGPTL8 ANTIBODIES AND THEIR APPLICATION
EA202190377A9 (en) CXCR4 INHIBITOR COMPOSITIONS AND METHODS FOR PREPARATION AND APPLICATION
EA201691070A1 (en) NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS
EA201591401A1 (en) SPIROLACTAM NMDA-RECEPTOR MODULATORS AND THEIR APPLICATION
MX2017014191A (en) Methods of treating a neurodegenerative disease.
PH12018501903A1 (en) Methods of treating depression using orexin-2 receptor antagonists
EA201890245A1 (en) SUBSTITUTED 4-AZAINDOLS AND THEIR APPLICATION AS GLUN2B RECEPTOR MODULATORS
EA201591404A1 (en) SPIROLACTAM NMDA RECEPTOR MODULATORS AND THEIR APPLICATION
MX2021015500A (en) Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators.
CL2021003257A1 (en) Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators.
ECSP21090478A (en) SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
EA202091731A1 (en) AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
TW201713333A (en) Methods of treating a neurodegenerative disease
EA201991650A1 (en) METHODS FOR TREATING NEUROLOGICAL DISORDERS
EA202090513A1 (en) AGENTS MODULATING THE FUNCTIONS OF BETA-CATENIN AND RELATED METHODS
PH12020552059A1 (en) Dosing regimen for the treatment of pi3k related disorders
EA202092748A1 (en) APOL1 EXPRESSION MODULATORS
EA201892529A1 (en) COMBINATION OF PURE ANTAGONISTS OF 5-HTRECEPTORS WITH ACETYLHOLINESTERASE INHIBITORS
MX2022011310A (en) Azabicyclo and diazepine derivatives for treating ocular disorders.
EA202191058A1 (en) ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION
EA202092273A1 (en) BICYCLIC CARBOXAMIDES AND METHODS OF THEIR APPLICATION
PH12021550671A1 (en) Prodrugs of cgrp antagonists